Tonix Pharmaceuticals Holding C (TNXP) Financials

TNXP Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 139.3 million 18.4 million
2023-06-30 159.7 million 19.3 million
2023-03-31 179.1 million 13.7 million
2022-12-31 225.7 million 18.5 million

TNXP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -25.2 million 2.1 million
2023-06-30 -25.2 million 2.4 million
2023-03-31 -36.7 million 2.8 million
2022-12-31 -27.0 million 2.7 million

TNXP Net Income

No data available :(

TNXP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 6.9 million - 1.2 million
2023-06-30 25.6 million - 1.3 million
2023-03-31 72.0 million - 1.0 million
2022-12-31 120.2 million - 760000

TNXP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 15.3 million
2023-06-30 10.6 million
2023-03-31 10.1 million
2022-12-31 61.4 million

TNXP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1.8 million 21.1 million 8.7 million -
2023-06-30 1.8 million 22.0 million 7.0 million -
2023-03-31 3.8 million 26.5 million 7.4 million -
2022-12-31 4.7 million 24.7 million 8.1 million -

TNXP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 4.0 million 2.4 million
2023-06-30 - 29.0 million
2023-03-31 33.9 million 893000
2022-12-31 - 836000

TNXP

Price: $0.18

52 week price:
0.12
3.31

Earnings Per Share: -6.85 USD

P/E Ratio: -0.04

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 943700

Ebitda: -5.8 million

Market Capitalization: 17.5 million

Links: